Health Enhancement Products, Inc. and HEPI Pharmaceuticals, Inc. Announce Resignation of CEO
07. September 2007 21:30 ET
|
Health Enhancement Products, Inc.
SCOTTSDALE, AZ--(Marketwire - September 7, 2007) - Health Enhancement Products, Inc. (OTCBB: HEPI) and HEPI Pharmaceuticals, Inc., its wholly owned subsidiary,
announced today that Thomas D. Ingolia...
Health Enhancement Products, Inc. Announces Teleconference to Discuss Clinical Trial Stoppage
01. September 2007 17:16 ET
|
Health Enhancement Products, Inc.
SCOTTSDALE, AZ,--(Marketwire - September 1, 2007) - Health Enhancement Products, Inc. (OTCBB: HEPI), the maker of ProAlgaZyme®, will host a teleconference call on
Tuesday, September 4 at 9 AM...
HEPI Pharmaceuticals, Inc. Stops Trial of ProAlgaZyme(R) Due to Concerns Raised by Inconsistent Results
31. August 2007 19:30 ET
|
Health Enhancement Products, Inc.
SCOTTSDALE, AZ--(Marketwire - August 31, 2007) - HEPI Pharmaceuticals, Inc. and its parent
company, Health Enhancement Products, Inc. (OTCBB: HEPI), the maker of
ProAlgaZyme®, announced today...
Health Enhancement Products Announces Dr. Robert Cohen to Join Scientific Advisory Board
12. Juli 2007 08:00 ET
|
Health Enhancement Products, Inc.
SCOTTSDALE, AZ--(Marketwire - July 12, 2007) - Health Enhancement Products, Inc. (OTCBB: HEPI) (the "Company") announced today that Dr. Robert Cohen has joined its
Scientific Advisory Board,...
HEPI Pharmaceuticals, Inc. Files Patent Application to Protect Potential Active Components of ProAlgaZyme(R)
27. Juni 2007 08:00 ET
|
Health Enhancement Products, Inc.
SCOTTSDALE, AZ,--(Marketwire - June 27, 2007) - HEPI Pharmaceuticals, Inc., a subsidiary of
Health Enhancement Products, Inc. (OTCBB: HEPI), the makers of
ProAlgaZyme®, announced today the...
Health Enhancement Products Announces Exhibition Booth at 70th Annual Natural Products Trade Show and Convention in Las Vegas on July 20-22
14. Juni 2007 08:00 ET
|
Health Enhancement Products, Inc.
SCOTTSDALE, AZ--(Marketwire - June 14, 2007) - Health Enhancement Products, Inc. (OTCBB: HEPI), the makers of ProAlgaZyme, announced today they will be exhibiting
and introducing ProAlgaZyme to...
HEPI Pharmaceuticals, Inc. Announces Initiation of U.S.-Based Clinical Trial of ProAlgaZyme to Corroborate Previous Clinical Trial Results in Metabolic Syndrome
22. März 2007 08:00 ET
|
HEPI Pharmaceuticals, Inc.
SCOTTSDALE, AZ -- (MARKET WIRE) -- March 22, 2007 -- HEPI Pharmaceuticals, Inc., a wholly owned
subsidiary of Health Enhancement Products, Inc. (OTCBB: HEPI), announced
today that an Institutional...
Health Enhancement Products, Inc. to Distribute Shares of Pharmaceutical Subsidiary to Shareholders
21. Februar 2007 08:30 ET
|
Health Enhancement Products, Inc.
SCOTTSDALE, AZ -- (MARKET WIRE) -- February 21, 2007 -- Health Enhancement Products, Inc. (OTCBB: HEPI) announced today that on February 15, 2007, its board of directors
declared a distribution in the...
Health Enhancement Products to Create Pharmaceutical Division to Pursue Potential Pharmaceutical Applications for ProAlgaZyme
25. Januar 2007 08:30 ET
|
Health Enhancement Products, Inc.
SCOTTSDALE, AZ -- (MARKET WIRE) -- January 25, 2007 -- Health Enhancement Products, Inc. (OTCBB: HEPI) announced today that it is in the process of creating a new
pharmaceutical division, to be...
Health Enhancement Products Announces Final Results of Clinical Trials of ProAlgaZyme in Metabolic Syndrome and HIV Patients
19. Januar 2007 08:30 ET
|
Health Enhancement Products, Inc.
SCOTTSDALE, AZ -- (MARKET WIRE) -- January 19, 2007 --Health Enhancement Products, Inc. (OTCBB: HEPI), a Scottsdale Arizona company, announced today the final results of
two clinical trials involving...